News > Article

Therapeutic developed by Macdonald and Gray receives FDA orphan drug approval

University of Virginia start-up company Tau Therapeutics LLC has been granted Food and Drug Administration orphan drug status for a pioneering treatment for pancreatic cancer.

Developed by U.Va. inventors Timothy L. Macdonald, Dr. Lloyd S. Gray and collaborators, the treatment takes a revolutionary approach to the fight against cancer.

Unlike many existing cancer therapies, which are designed to attack cancer cells and often damage healthy cells in the process, the researchers’ treatment inhibits tumor growth by blocking the entry of calcium into cancer cells. Read more …


Tagged as: ,